EVR.L

EVRAZ Plc
EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
19th December 2022, 11:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

EVRAZ plc (EVR)
EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective

19-Dec-2022 / 14:00 MSK
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION MEMORANDUM.

EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023 have become effective

London, 19 December 2022 – on 15 November 2022, EVRAZ plc (the “Issuer”) announced a consent solicitation in relation to the outstanding U.S.$750,000,000 5.375 per cent. notes due 2023 issued by the Issuer (Regulation S Notes: Common Code 153391572 / ISIN XS1533915721; Rule 144A Notes: Common Code 111731110 / ISIN US30050AAG85 / CUSIP 30050AAG8) (the “Notes”) on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the “Consent Solicitation Memorandum”). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum.

The Issuer notifies that, on 19 December 2022, (i) the Issuer and the New Trustee entered into the Deed of Appointment to effectuate the Appointment; and (ii) the Issuer and the New Trustee entered into the Supplemental Trust Deed to effectuate the Amendments. Accordingly, the Appointment and the Amendments have become effective and binding on all Noteholders with effect from that date.

The Issuer extends its gratitude for the support and cooperation demonstrated by investors which has been reflected in the successful results of the Consent Solicitation.

 

 

Questions and requests for assistance in connection with the Consent Solicitation should be directed to the Information and Tabulation Agent:

Limited liability company “Legal Capital Investor Services”

Address:  10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia

Email:   evraz@lcpis.ru

Phone:   +7 495 122 05 17

Website:  www.lcpis.ru

 

###

For further information:

 

Investor Relations

+7 495 232 1370

ir@evraz.com

 
ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCM
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 209693
EQS News ID: 1516489

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1516489&application_name=news&site_id=acquiremedia3]]>
TwitterFacebookLinkedIn